Trellis Bioscience: Funding, Investors & Team (Oct 2026)
Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.
Trellis Bioscience has raised $15.1M across 2 funding rounds on record, the most recent a Series C of $9.0M announced in Jul 2026.
That round is in line with the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Trellis Bioscience Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Trellis Bioscience Funding Rounds
Trellis Bioscience raised $6.1M in a Series C announced in May 2026.
2 months later, a Series C of $9.0M was announced in Jul 2026.
Trellis Bioscience Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
Trellis Bioscience Founders and Leadership Team
Contact details for the Trellis Bioscience team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Trellis Bioscience Funding Compared to Other Biotechnology Startups
Trellis Bioscience's latest round of $9.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Trellis Bioscience in Biotechnology and San Francisco
Companies Similar to Trellis Bioscience
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Trellis Bioscience Funding FAQs
What does Trellis Bioscience do?
Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.
How much funding has Trellis Bioscience raised?
Trellis Bioscience has raised $15.1M across 2 rounds on record. The most recent is a Series C of $9.0M announced in Jul 2026.
When did Trellis Bioscience last raise funding?
Trellis Bioscience's most recent funding round on record is a Series C of $9.0M, announced in Jul 2026.
Who has invested in Trellis Bioscience?
Investors on record for Trellis Bioscience include The Doctor Group, AMR Action Fund, New Science Ventures, CARB-X, Novartis Venture Fund. FundedIQ records 10 investors in total.
Who founded Trellis Bioscience?
FundedIQ lists Stefan Ryser (Founder) at Trellis Bioscience.
Who is the CEO of Trellis Bioscience?
Brian Cunningham is listed as CEO at Trellis Bioscience.
Where is Trellis Bioscience headquartered?
Trellis Bioscience is based in San Francisco, California, United States.
How many employees does Trellis Bioscience have?
Trellis Bioscience is in the 11-50 employee band.
When was Trellis Bioscience founded?
Trellis Bioscience was founded in 1998.
How does Trellis Bioscience's funding compare to other Biotechnology startups?
Trellis Bioscience's latest round of $9.0M is in line with the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Trellis Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Trellis Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.